Russian-Language Labeling and Instructions for Use Requirements

1. Key takeaways

Russian registration dossier documents, product labels, and instructions for use must be in the Russian language. This is not a translation step to be scheduled just before delivery; it is compliance content in its own right. The language of the documents determines whether users can operate the device safely, and the regulator treats language quality as part of device safety rather than as a matter of presentation. Poorly worded Russian instructions are therefore a regulatory defect, not merely an aesthetic one.

From September 1, 2026, unclear statements in instructions and labels can themselves become the subject of adverse event handling, and the regulator includes the readability of Russian-language information in its assessments. This raises the stakes for translation work considerably: a warning that is technically present but linguistically confusing can be judged as effectively absent. Manufacturers should treat Russian-language documentation as a regulated deliverable with the same change control, review, and record-keeping discipline as any other part of the technical file.

The practical consequence is that Russian-language work belongs at the beginning of the project, not at the end. The intended-purpose statements, warnings, and contraindications that will appear in Russian determine how the classification is argued, how the testing scope is framed, and how the label mock-ups are built. Translating after these decisions are fixed locks in source texts that may be hard to render clearly, and reworking them later triggers amendments to the registration file. Teams that write the key Russian formulations early, and review every later source-text change against them, keep the language layer and the regulatory layer moving in step instead of in conflict.

2. Legal basis

3. Expert insights

Insight 1: The language requirement runs through three layers of documents. The documents on technical characteristics and format, the operating documents (instructions for use), and the labels and packaging mock-ups must all be in Russian. Decision No. 27 additionally imposes a content checklist for labeling and operating documents on the union pathway. When selecting a translation provider, the standard should be consistency of medical device terminology across the whole dossier, not the lowest unit price, because a term that shifts between the technical file, the instructions, and the label reads as an inconsistency to the expert reviewer and to the market surveillance inspector alike.

Insight 2: The Russian text becomes an object of adverse event assessment. Order No. 540n takes into account use risks arising from user comprehension difficulties. Contradictory instructions, missing warnings, and labels on which the model or batch cannot be identified can all enter the assessment scope and lead to regulatory measures. In practice this means the Russian documentation is scrutinized not only at registration but throughout the device lifetime, and every update to the source-language instructions must be mirrored promptly and accurately in the Russian text.

Insight 3: Model identification and coding must be consistent. From September 1, 2026, the mandatory digital identification requirements for newly added product categories require coding to be completed before release, and the model, batch, and Data Matrix content on the label must match the register record. Where the label, the register, and the coded data disagree, the discrepancy is easy for an inspector to find, since all three sources are machine-readable, and reconciliation after the fact is far more costly than getting the data right before release.

4. Practical recommendations

1. Build a Chinese-Russian and English-Russian terminology base for the product line, and run a consistency check at every update of the instructions for use, so that terminology drift between versions is caught before submission.
2. Commission a native Russian review of every label mock-up before submission, focused on warnings, contraindications, and handling steps, where comprehension failures carry the highest safety consequences.
3. Bring instruction updates into change control: a content change can trigger a register amendment and start the statutory time limits, so the translation update should be an item in the change record, not an afterthought.
4. Verify that label content, register data, and coding data agree before each release of a coded product category, and retain the verification evidence in the project file.

5. Verification checklist

• □ Technical documents, operating documents, and labels are all available in Russian versions
• □ The Russian instructions contain complete statements of the model, batch, warnings, and contraindications
• □ Union-pathway products have been checked against the labeling and operating document content checklist of Decision No. 27
• □ Union-registered products carry the unified circulation mark on the packaging (Decision No. 26)
• □ Label content matches the register record and the coding data

GRZAN provides Russian-language documentation services for medical device manufacturers, including translation of technical and operating documents with medical device terminology control, native-speaker label review against EEC Decision No. 27, and alignment of label content with register records and digital coding under the requirements effective September 1, 2026. Our documentation work is integrated with change control so that every language update stays within the statutory deadlines. For labeling, translation, and RZN registration support in Russia, contact GRZAN at info@grzanglobal.com.

Regulatory information verified as of October 29, 2026.